Aerie Pharmaceuticals, Inc.

NC · United States · Reporting entity ID 100000216803

Total reported 2019–2025

$12.4M

#433 of 2,960 reporting companies — 0% of all reported industry payments

$7.54M in general payments across 46,542 records, plus $4.86M in research funding across 500 records.

How it breaks down

General payments $7,540,061

Research funding $4,863,246

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.